Buying practices is the fastest way to grow a healthcare platform's EBITDA. It is also the growth buyers trust least. When a platform goes to market, the first question in diligence is usually how the locations it already owned performed year over year. Strong same-store growth shows the platform can make practices better. Weak same-store growth suggests it has only been adding them up.
Why Same-Store Growth Drives the Multiple
- It proves the operating model. Growth at existing locations shows that the platform adds value after close, not just at close.
- It is repeatable. A buyer can apply the same improvements to future acquisitions and underwrite that growth in their own model.
- It does not depend on the deal pipeline. Acquisition-driven growth stops when the pipeline slows or multiples rise. Organic growth keeps going.
- It is cleaner EBITDA. Fewer pro forma adjustments, fewer add-backs and fewer questions in the quality of earnings report.
Where Same-Store Revenue Leaks
Most outpatient locations have more demand than they capture. The leaks are familiar:
- Missed and abandoned calls, especially at lunch, after hours and on Monday mornings
- No-shows and late cancellations that leave chairs and exam rooms empty
- Overdue recall: patients due for a cleaning, follow-up or annual visit who were never contacted
- Unscheduled treatment: recommended care that the patient never booked
- Slow follow-up on web leads, which often go cold within hours
- Few reviews, which lowers local search visibility for every location
None of these require a new provider or a new building to fix. They require consistent follow-through, which is exactly what a busy front desk struggles to deliver.
The AI Levers, Location by Location
| Leak | What AI does | KPI it moves |
|---|---|---|
| Missed calls | Answers and books 24/7 | New-patient bookings |
| No-shows | Confirms, reminds, reschedules | Show rate |
| Open slots | Fills from waitlist and recall | Schedule fill rate |
| Overdue recall | Runs recall campaigns continuously | Recall reactivation |
| Unscheduled treatment | Follows up on open treatment plans | Treatment acceptance |
| Low visibility | Requests reviews after each visit | Review volume and rating |
Operations Engine (AIT) runs these workflows at every location, and Rollup Engine (AIP) connects each location's EHR and PMS so the same playbook works everywhere and results are reported on the same definitions.
Make It Show Up in Diligence
Same-store growth only helps at exit if a buyer can verify it. That means:
- Baseline every location before go-live, so improvements are measured, not estimated.
- Use the same KPI definitions everywhere, so a fill rate in one state means the same thing as a fill rate in another.
- Attribute the change: show which workflows moved which numbers.
- Keep the history, so the data room has two or three years of location-level trends.
For more on preparing a platform for sale, see the AI-ready exit and revenue-first AI for healthcare roll-ups.
Next Step
Estimate the same-store upside across your locations with the ROI calculator, or book a demo to see the location-level reporting.
Frequently Asked Questions
What is same-store growth in a healthcare roll-up?
Same-store growth is the year-over-year change in revenue or EBITDA at locations the platform owned in both periods, excluding the effect of new acquisitions.
Why do buyers care about same-store growth?
It shows that the platform's operating model improves practices after they are acquired, which a buyer can repeat on future acquisitions and underwrite in their valuation.
How does AI increase same-store revenue?
AI answers missed calls, reduces no-shows, fills open slots, runs recall, follows up on unscheduled treatment and requests reviews, all of which raise revenue at existing locations without adding staff.